510(k) device
FLC Kappa, FLC Lambda,FLC Control Level 1, FLC Control Level 2
Sebia · Kappa, Antigen, Antiserum, Control (DFH, Class II) · First FDA decision Nov 18, 2022, newest Feb 23, 2024Cancer detection and genomic testing
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
3
Naming "FLC"
MAUDE reports
120
Brand "FLC", since 2015
PubMed studies
3,600
Mentioning "FLC"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing FLC Kappa, FLC Lambda,FLC Control Level 1, FLC Control Level 2
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K231601 · Decided Feb 23, 2024 · 267 days after receipt
Device type: Kappa, Antigen, Antiserum, Control (DFH) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "FLC", any status and sponsor, newest update first.
- Kidney Therapy for Free Light Chain Removal in Patients With Multiple Myeloma & Cast NephropathyCompleted
Azienda USL Reggio Emilia - IRCCSGovernment (non-federal)
NCT02358980 · 5 participants · Start Feb 18, 2015 · Primary completion Sep 30, 2018
Device: KIDNEY therapy · For: Multiple Myeloma; Cast Nephropathy; Acute Kidney Injury
Sites: Reggio Emilia, Italy
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "FLC", and for the whole product code for context.
This brand
120 reports: 114 malfunction, 6 injury, 0 death
Whole product code DFH
63 reports: 53 malfunction, 10 injury, 0 death
Newest reports for this brand
- N Latex FLC kappaMalfunction
Siemens Healthcare Diagnostics Products GmbH
9610806-2026-00038 · Received Oct 14, 2026 · Event dated Sep 23, 2026
Device type: Kappa, Antigen, Antiserum, Control (DFH)
Device problem as coded: Low Test Results
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "FLC"[tiab]. The summary above synthesizes these.
- The FLC Locus: A Platform for Discoveries in Epigenetics and Adaptation.
Whittaker C, Dean C · Annu Rev Cell Dev Biol · 2017Review, Research Support, Non-U.S. Gov't
- Cold-induced Arabidopsis FRIGIDA nuclear condensates for FLC repression.
Zhu P, Lister C, Dean C · Nature · 2021Research Support, Non-U.S. Gov't
- Liver cancer multiomics reveals diverse protein kinase A disruptions convergently produce fibrolamellar hepatocellular carcinoma.
Requena D, Medico JA, Soto-Ugaldi LF, et al. · Nat Commun · 2024Research Support, U.S. Gov't, P.H.S., Research Support, N.I.H., Extramural
- Vernalization attenuates dehydration tolerance in winter-annual Arabidopsis.
Chen L, Hu P, Lu Q, et al. · Plant Physiol · 2022Research Support, Non-U.S. Gov't
- New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance.
Einarsson Long T, Rognvaldsson S, Thorsteinsdottir S, et al. · JAMA Oncol · 2025
- GalNAc-conjugated siRNA targeting the DNAJB1-PRKACA fusion junction in fibrolamellar hepatocellular carcinoma.
Neumayer C, Ng D, Requena D, et al. · Mol Ther · 2024Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- How is FLC repression initiated by cold?
Helliwell CA, Anderssen RS, Robertson M, et al. · Trends Plant Sci · 2015Review
- Integrating analog and digital modes of gene expression at Arabidopsis FLC.
Antoniou-Kourounioti RL, Meschichi A, Reeck S, et al. · Elife · 2023Research Support, Non-U.S. Gov't
- Tmsb10 triggers fetal Leydig differentiation by suppressing the RAS/ERK pathway.
Inoue M, Baba T, Takahashi F, et al. · Commun Biol · 2022Research Support, Non-U.S. Gov't
- Total FLC transcript dynamics from divergent paralogue expression explains flowering diversity in Brassica napus.
Calderwood A, Lloyd A, Hepworth J, et al. · New Phytol · 2021Research Support, Non-U.S. Gov't
- International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.
Dispenzieri A, Kyle R, Merlini G, et al. · Leukemia · 2009Practice Guideline, Review
- Fibrolamellar hepatocellular carcinoma: current clinical perspectives.
Lafaro KJ, Pawlik TM · J Hepatocell Carcinoma · 2015Review
Other devices of this type
Also filed under product code DFH.
- N Latex FLC kappa, N Latex FLC lambdaSiemens Healthcare Diagnostics Products GmbH · 510(k) 2022
- Diazyme Human Kappa (k) Free Light Chain AssayDiazyme Laboratories, Inc. · 510(k) 2025
- Freelite Human Kappa and Lambda Free Diagnostic Test Kits for Use on the Roche Cobas Integra 400/400 Plus Analyzer KitThe Binding Site, Ltd. · 510(k) 2007
- Optilite® Freelite Mx Kappa Free KitThe Binding Site Group , Ltd. · 510(k) 2025
- Optilite® Freelite® Kappa Free Kit, Optilite® Freelite® Lambda Free KitThe Binding Site, Ltd. · 510(k) 2024
- Optilite FreeLite Kappa Free Kit, Optilite Freelite Lambda Free KitThe Binding Site Group , Ltd. · 510(k) 2015
- Human Kappa and Lambda Free Kitfor Use on the Spa Plus AnalyserThe Binding Site Group , Ltd. · 510(k) 2013
- Kappa Light ChainsSENTINEL CH. SpA · 510(k) 2009
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.